Your browser doesn't support javascript.
loading
Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.
Dejoie, Thomas; Corre, Jill; Caillon, Helene; Hulin, Cyrille; Perrot, Aurore; Caillot, Denis; Boyle, Eileen; Chretien, Marie-Lorraine; Fontan, Jean; Belhadj, Karim; Brechignac, Sabine; Decaux, Olivier; Voillat, Laurent; Rodon, Philippe; Fitoussi, Olivier; Araujo, Carla; Benboubker, Lotfi; Fontan, Charlotte; Tiab, Mourad; Godmer, Pascal; Luycx, Odile; Allangba, Olivier; Pignon, Jean-Michel; Fuzibet, Jean-Gabriel; Legros, Laurence; Stoppa, Anne Marie; Dib, Mamoun; Pegourie, Brigitte; Orsini-Piocelle, Frederique; Karlin, Lionel; Arnulf, Bertrand; Roussel, Murielle; Garderet, Laurent; Mohty, Mohamad; Meuleman, Nathalie; Doyen, Chantal; Lenain, Pascal; Macro, Margaret; Leleu, Xavier; Facon, Thierry; Moreau, Philippe; Attal, Michel; Avet-Loiseau, Herve.
  • Dejoie T; Biochemistry Laboratory and Hematology Department, Centre Hospitalier Universitaire (CHU), Nantes, France.
  • Corre J; Institut Universitaire du Cancer, CHU, Centre de Recherche en Cancérologie de Toulouse, INSERM 1037, Toulouse, France.
  • Caillon H; Biochemistry Laboratory and Hematology Department, Centre Hospitalier Universitaire (CHU), Nantes, France.
  • Hulin C; Hematology Department, CHU, Bordeaux, France.
  • Perrot A; Hematology Department, CHU, Nancy, France.
  • Caillot D; Hematology Department, CHU, Dijon, France.
  • Boyle E; Hematology Department, CHU, Lille, France.
  • Chretien ML; Hematology Department, CHU, Dijon, France.
  • Fontan J; Hematology Department, CHU, Besancon, France.
  • Belhadj K; Hematology Department, CHU, Creteil, France.
  • Brechignac S; Hematology Department, CHU, Bobigny, France.
  • Decaux O; Internal Medicine, CHU, Rennes, France.
  • Voillat L; Centre Hospitalier William Morey, Departmental Hospital, Chalon, France.
  • Rodon P; Clinical Research Unit, Centre Hospitalier de Périgueux, Departmental Hospital, Perigueux, France.
  • Fitoussi O; Hematology Department, Polyclinique Bordeaux-Nord, Bordeaux, France.
  • Araujo C; Centre Hospitalier Departemental, Bayonne, France.
  • Benboubker L; Hôpital Bretonneau, CHU, Tours, France.
  • Fontan C; Institut Universitaire du Cancer, CHU, Centre de Recherche en Cancérologie de Toulouse, INSERM 1037, Toulouse, France.
  • Tiab M; Centre Hospitalier Departemental, La Roche sur Yon, La Roche/Yon, France.
  • Godmer P; Centre Hospitalier Departemental, Vannes, France.
  • Luycx O; Centre Hospitalier Departemental, Lorient, France.
  • Allangba O; Centre Hospitalier Departemental, Saint-Brieuc, France.
  • Pignon JM; Centre Hospitalier Departemental, Dunkerque, France.
  • Fuzibet JG; Internal Medicine, CHU, Nice, France.
  • Legros L; Internal Medicine, CHU, Nice, France.
  • Stoppa AM; Hematology Department, Institut Paoli Calmette, Marseille, France.
  • Dib M; Hematology Department, CHU, Angers, France.
  • Pegourie B; Hematology Department, CHU, Grenoble, France.
  • Orsini-Piocelle F; Hematology Department, Centre Hospitalier Departemental, Annecy, France.
  • Karlin L; Hematology Department, CHU, Lyon, France.
  • Arnulf B; Immunopathology Service, Saint-Louis University Hospital, Paris, France.
  • Roussel M; Institut Universitaire du Cancer, CHU, Centre de Recherche en Cancérologie de Toulouse, INSERM 1037, Toulouse, France.
  • Garderet L; Hematology Department, Saint-Antoine University Hospital, Paris, France.
  • Mohty M; Hematology Department, Saint-Antoine University Hospital, Paris, France.
  • Meuleman N; Department of Clinical and Experimental Hematology, Jules Bordet Institute, Brussels, Belgium.
  • Doyen C; Department of Clinical and Experimental Research, Clinique Universitaire Mont-Godinne, Yvoir, Belgium.
  • Lenain P; Hematology Department, Centre Henri Becquerel, Rouen, France.
  • Macro M; Hematology Department, CHU, Caen, France; and.
  • Leleu X; Hematology Department, CHU, Poitiers, France.
  • Facon T; Hematology Department, CHU, Lille, France.
  • Moreau P; Biochemistry Laboratory and Hematology Department, Centre Hospitalier Universitaire (CHU), Nantes, France.
  • Attal M; Institut Universitaire du Cancer, CHU, Centre de Recherche en Cancérologie de Toulouse, INSERM 1037, Toulouse, France.
  • Avet-Loiseau H; Institut Universitaire du Cancer, CHU, Centre de Recherche en Cancérologie de Toulouse, INSERM 1037, Toulouse, France.
Blood ; 128(25): 2941-2948, 2016 12 22.
Article en En | MEDLINE | ID: mdl-27729323
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cadenas Ligeras de Inmunoglobulina / Mieloma Múltiple Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Humans / Middle aged Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cadenas Ligeras de Inmunoglobulina / Mieloma Múltiple Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Adult / Humans / Middle aged Idioma: En Año: 2016 Tipo del documento: Article